Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5719328

C=CCn1c(N2CCNCC2)nc2c1c(=O)n(CCOC)c(=O)n2C.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 10/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
ALDH1A1 P00352 2/20 0.51
LMNA P02545 1/20 0.51
HTT P42858 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
MAPT P10636 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSD17B10 Q99714 1/20 0.43
FAP Q12884 2/20 0.42
DPP9 Q86TI2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5718941 0.92 DPP4 (0.58) DPP4L3MBTL1ALDH1A1LMNAHTT
Trifluoroacetic Acid SCHEMBL5719295 0.91 DPP4 (0.66) DPP4ALDH1A1LMNASMN1; SMN2
Trifluoroacetic Acid SCHEMBL5719120 0.90 DPP4 (0.55) DPP4L3MBTL1ALDH1A1LMNAHTT
Trifluoroacetic Acid SCHEMBL5719360 0.89 DPP4 (0.56) DPP4L3MBTL1ALDH1A1LMNAHTT
SCHEMBL5719124 0.89 DPP4 (0.53) DPP4L3MBTL1ALDH1A1LMNAHTT
Trifluoroacetic Acid SCHEMBL5719241 0.89 DPP4 (0.57) DPP4L3MBTL1ALDH1A1LMNAHTT
Trifluoroacetic Acid SCHEMBL5788813 0.87 DPP4 (0.55) DPP4L3MBTL1ALDH1A1LMNAHTT
Trifluoroacetic Acid SCHEMBL5718835 0.87 DPP4 (0.68) DPP4L3MBTL1ALDH1A1LMNAHTT
Trifluoroacetic Acid SCHEMBL5719165 0.86 LMNA (0.57) DPP4L3MBTL1ALDH1A1LMNAHTT
Trifluoroacetic Acid SCHEMBL5719162 0.86 DPP4 (0.66) DPP4FAPDPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1338595-B1 Xanthine derivatives as DPP-IV inhibitors EISAI CO LTD (JP) 2006-05-03 EP disclosed
EP-1338595-A2 Xanthine derivatives as DPP-IV inhibitors Eisai Co., Ltd. (JP) 2003-08-27 EP disclosed